Preparation and physicochemical characterization of prazosin conjugated PLGA nanoparticles for drug delivery of flutamide
AUTOR(ES)
Fattahi, Ali
FONTE
Braz. J. Pharm. Sci.
DATA DE PUBLICAÇÃO
08/04/2019
RESUMO
In the current work, a sustained drug delivery system of flutamide (FLT) was developed using Poly(D,L-lactide-co-glycolide) (PLGA) decorated bypoly(ethylene glycol) (PEG) grafted prazosin (PLGA-PEG-Praz) as a targeting moiety. In a multi-step reaction, PLGA was linked to PEG and prazosin. The structure of the synthesized polymers was confirmed by FTIR and 1H-NMR. Flutamide-loaded nanoparticles were prepared by quasi-emulsion solvent diffusion technique. The nanoparticles were evaluated for size, zeta potential, polydispersity index, drug crystallinity, loading efficiency, and release properties. Also, the physicochemical properties of the nanoparticles were analyzed using Scanning Electron Microscopy (SEM), Differential Scanning Calorimetry, and Powder X-Ray Diffractometry (XRD). The particle size of nanoparticles was ranged between 191 and 249 nm. Loading efficiency of nanoparticles was about 43%-69%. Results showed a steady release rate for nanoparticles compared to that of a pure drug powder. SEM characterization confirmed that particles were in nanosize range. DSC and XRPD results verified a decrease in drug crystallinity in the prepared formulations. In conclusion, the results of this study showed that PLGA-PEG-Praz nanoparticles could be a good choice to improve the physicochemical properties of the drug and these formulations can increase Flutamide efficacy.
Documentos Relacionados
- Preparation and characterization of novel, mucoadhesive ofloxacin nanoparticles for ocular drug delivery
- Preparation and physicochemical characterization of dioctyl sodium sulfosuccinate (aerosol OT) microemulsion for oral drug delivery
- Evaluation of polymeric PLGA nanoparticles conjugated to curcumin for use in aPDT
- Nanoparticles and microparticles for drug and vaccine delivery.
- Trojan particles: Large porous carriers of nanoparticles for drug delivery